Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. vs SHILPA MEDICARE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MARKSANS PHARMA. SHILPA MEDICARE MARKSANS PHARMA./
SHILPA MEDICARE
 
P/E (TTM) x 40.1 137.1 29.3% View Chart
P/BV x 6.8 5.0 134.3% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 MARKSANS PHARMA.   SHILPA MEDICARE
EQUITY SHARE DATA
    MARKSANS PHARMA.
Mar-24
SHILPA MEDICARE
Mar-24
MARKSANS PHARMA./
SHILPA MEDICARE
5-Yr Chart
Click to enlarge
High Rs179469 38.2%   
Low Rs70228 30.5%   
Sales per share (Unadj.) Rs48.0132.7 36.2%  
Earnings per share (Unadj.) Rs6.93.7 188.8%  
Cash flow per share (Unadj.) Rs8.616.1 53.3%  
Dividends per share (Unadj.) Rs0.600-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs45.6208.4 21.9%  
Shares outstanding (eoy) m453.1686.80 522.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.62.6 98.5%   
Avg P/E ratio x17.994.7 18.9%  
P/CF ratio (eoy) x14.521.6 66.9%  
Price / Book Value ratio x2.71.7 163.1%  
Dividend payout %8.60-   
Avg Mkt Cap Rs m56,33330,246 186.2%   
No. of employees `000NANA-   
Total wages/salary Rs m2,9362,815 104.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m21,77411,516 189.1%  
Other income Rs m504166 303.9%   
Total revenues Rs m22,27811,682 190.7%   
Gross profit Rs m4,5862,374 193.1%  
Depreciation Rs m7431,079 68.9%   
Interest Rs m112918 12.2%   
Profit before tax Rs m4,235543 779.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,086224 485.3%   
Profit after tax Rs m3,149320 985.4%  
Gross profit margin %21.120.6 102.2%  
Effective tax rate %25.641.2 62.3%   
Net profit margin %14.52.8 521.2%  
BALANCE SHEET DATA
Current assets Rs m18,6258,768 212.4%   
Current liabilities Rs m3,8986,933 56.2%   
Net working cap to sales %67.615.9 424.5%  
Current ratio x4.81.3 377.8%  
Inventory Days Days1032 31.0%  
Debtors Days Days761,243 6.1%  
Net fixed assets Rs m8,18522,061 37.1%   
Share capital Rs m45387 522.1%   
"Free" reserves Rs m20,19718,000 112.2%   
Net worth Rs m20,65118,087 114.2%   
Long term debt Rs m05,602 0.0%   
Total assets Rs m26,81030,829 87.0%  
Interest coverage x38.81.6 2,437.6%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.80.4 217.4%   
Return on assets %12.24.0 303.0%  
Return on equity %15.21.8 863.1%  
Return on capital %21.16.2 341.2%  
Exports to sales %024.5 0.0%   
Imports to sales %6.90.7 938.1%   
Exports (fob) Rs mNA2,824 0.0%   
Imports (cif) Rs m1,51185 1,773.7%   
Fx inflow Rs m8,4662,912 290.7%   
Fx outflow Rs m1,511465 325.2%   
Net fx Rs m6,9542,448 284.1%   
CASH FLOW
From Operations Rs m2,3041,353 170.2%  
From Investments Rs m-1,408-1,666 84.5%  
From Financial Activity Rs m-687468 -146.9%  
Net Cashflow Rs m208114 183.5%  

Share Holding

Indian Promoters % 43.9 44.3 99.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.4 17.8 143.1%  
FIIs % 21.3 9.6 222.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 56.1 55.7 100.8%  
Shareholders   248,845 42,784 581.6%  
Pledged promoter(s) holding % 0.0 7.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MARKSANS PHARMA. With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on MARKSANS PHARMA. vs SHILPA MEDICARE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

MARKSANS PHARMA. vs SHILPA MEDICARE Share Price Performance

Period MARKSANS PHARMA. SHILPA MEDICARE S&P BSE HEALTHCARE
1-Day -0.39% -0.62% 0.54%
1-Month 15.87% 17.05% -0.92%
1-Year 120.65% 150.81% 42.65%
3-Year CAGR 78.58% 19.71% 20.08%
5-Year CAGR 83.36% 25.14% 26.07%

* Compound Annual Growth Rate

Here are more details on the MARKSANS PHARMA. share price and the SHILPA MEDICARE share price.

Moving on to shareholding structures...

The promoters of MARKSANS PHARMA. hold a 43.9% stake in the company. In case of SHILPA MEDICARE the stake stands at 44.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of MARKSANS PHARMA. and the shareholding pattern of SHILPA MEDICARE.

Finally, a word on dividends...

In the most recent financial year, MARKSANS PHARMA. paid a dividend of Rs 0.6 per share. This amounted to a Dividend Payout ratio of 8.6%.

SHILPA MEDICARE paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of MARKSANS PHARMA., and the dividend history of SHILPA MEDICARE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.